As cancer, a deadly disease, evolves, our fight against it does so too. Today, there are multiple therapies and drugs available that fight different types of cancer. Now, researchers have added a new drug called Disarib to this list that acts against a particular protein called BCL2. By killing cells that overproduce this protein, the researchers claim that Disarib can act effectively against most types of cancers. A first kind of its drug made completely in India, Disarib heralds a new breakthrough in Indian pharmaceutical research.
क्षयरोग के जीवाणु प्रसुप्त अवस्था में अपने बाह्य आवरण में होने वाले परिवर्तन के कारण प्रतिजैविक (एंटीबायोटिक्स) से बच कर लंबे समय तक जीवित रह सकते हैं।
Mumbai/